Bank of America’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-44,500
Closed -$12.6M 7339
2025
Q3
$12.6M Sell
44,500
-283,600
-86% -$82.2M ﹤0.01% 3073
2025
Q2
$91.6M Sell
328,100
-274,900
-46% -$77.9M 0.01% 1216
2025
Q1
$188M Buy
603,000
+490,300
+435% +$145M 0.02% 753
2024
Q4
$29.4M Sell
112,700
-15,900
-12% -$4.72M ﹤0.01% 1954
2024
Q3
$41.4M Buy
128,600
+72,700
+130% +$23.8M ﹤0.01% 1729
2024
Q2
$17.5M Sell
55,900
-41,700
-43% -$12.3M ﹤0.01% 2386
2024
Q1
$27.7M Buy
97,600
+24,200
+33% +$7.08M ﹤0.01% 1970
2023
Q4
$21.1M Buy
73,400
+41,500
+130% +$11.3M ﹤0.01% 2108
2023
Q3
$8.57M Sell
31,900
-200
-0.6% -$49.9K ﹤0.01% 2869
2023
Q2
$7.13M Sell
32,100
-25,300
-44% -$5.87M ﹤0.01% 3046
2023
Q1
$13.9M Sell
57,400
-73,000
-56% -$17.9M ﹤0.01% 2502
2022
Q4
$34.2M Sell
130,400
-76,000
-37% -$20.4M ﹤0.01% 1582
2022
Q3
$46.5M Buy
206,400
+76,100
+58% +$18.4M 0.01% 1313
2022
Q2
$31.7M Buy
130,300
+55,700
+75% +$13.6M ﹤0.01% 1604
2022
Q1
$18M Sell
74,600
-80,800
-52% -$18.6M ﹤0.01% 2238
2021
Q4
$35M Sell
155,400
-115,200
-43% -$24.3M ﹤0.01% 1702
2021
Q3
$57.5M Sell
270,600
-68,900
-20% -$15.9M 0.01% 1265
2021
Q2
$82.8M Buy
339,500
+111,200
+49% +$27.4M 0.01% 1048
2021
Q1
$56.8M Buy
228,300
+114,100
+100% +$27.2M 0.01% 1209
2020
Q4
$26.3M Buy
114,200
+30,400
+36% +$7.01M ﹤0.01% 1648
2020
Q3
$21.3M Buy
83,800
+23,400
+39% +$5.8M ﹤0.01% 1652
2020
Q2
$14.2M Sell
60,400
-10,400
-15% -$2.37M ﹤0.01% 1903
2020
Q1
$14.4M Sell
70,800
-79,000
-53% -$17.3M ﹤0.01% 1762
2019
Q4
$36.1M Sell
149,800
-202,000
-57% -$44.5M 0.01% 1399
2019
Q3
$68.1M Sell
351,800
-154,400
-31% -$29.6M 0.01% 951
2019
Q2
$93.3M Buy
506,200
+96,600
+24% +$17.3M 0.01% 766
2019
Q1
$77.8M Buy
409,600
+152,300
+59% +$29.1M 0.01% 854
2018
Q4
$50.1M Buy
257,300
+31,400
+14% +$6.13M 0.01% 996
2018
Q3
$46.8M Buy
225,900
+58,100
+35% +$11.5M 0.01% 1151
2018
Q2
$31M Sell
167,800
-314,600
-65% -$55.6M 0.01% 1448
2018
Q1
$82.2M Sell
482,400
-367,400
-43% -$67.4M 0.01% 794
2017
Q4
$148M Buy
849,800
+1,600
+0.2% +$283K 0.02% 571
2017
Q3
$158M Sell
848,200
-30,800
-4% -$5.46M 0.03% 561
2017
Q2
$151M Sell
879,000
-34,200
-4% -$5.56M 0.03% 521
2017
Q1
$150M Sell
913,200
-120,200
-12% -$20M 0.03% 525
2016
Q4
$151M Buy
1,033,400
+54,600
+6% +$8.22M 0.03% 488
2016
Q3
$163M Buy
978,800
+62,400
+7% +$10.6M 0.04% 459
2016
Q2
$139M Buy
916,400
+215,800
+31% +$33.6M 0.03% 505
2016
Q1
$105M Sell
700,600
-284,100
-29% -$42.2M 0.03% 585
2015
Q4
$160M Buy
984,700
+169,700
+21% +$26.7M 0.04% 470
2015
Q3
$113M Sell
815,000
-60,600
-7% -$9.55M 0.03% 595
2015
Q2
$134M Buy
875,600
+412,900
+89% +$66.1M 0.04% 437
2015
Q1
$74M Sell
462,700
-373,500
-45% -$58.8M 0.02% 635
2014
Q4
$133M Buy
836,200
+120,900
+17% +$18.8M 0.05% 436
2014
Q3
$100M Buy
715,300
+175,100
+32% +$22.9M 0.03% 536
2014
Q2
$63.9M Buy
540,200
+335,600
+164% +$38.8M 0.02% 717
2014
Q1
$25.2M Sell
204,600
-124,400
-38% -$15.1M 0.01% 1138
2013
Q4
$37.5M Sell
329,000
-233,400
-42% -$26.5M 0.01% 904
2013
Q3
$62.9M Buy
562,400
+37,700
+7% +$4.09M 0.03% 625
2013
Q2
$51.8M Buy
+524,700
New +$54.4M 0.02% 684

Other funds holding AMGN

Bank of America's AMGN Position: Q1 2026 in Review

Bank of America reduced its Amgen (AMGN) stake by 7.5% in Q1 2026, selling an estimated $148M and leaving 5,121,028 shares worth $1.8B. The position accounts for 0.13% of the portfolio, ranked #166.

Bank of America first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.95B in Q3 2018. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank of America held 5,121,028 shares of Amgen worth $1.8B as of Q1 2026.
  • Bank of America sold 416,333 Amgen shares in Q1 2026, an estimated $148M.
  • Amgen made up 0.13% of Bank of America's portfolio in Q1 2026, its #166 holding.
  • Bank of America first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Amgen position peaked at $1.95B in Q3 2018.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.